- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
CytRx Corp+ Add to Watchlist
CYTR:US2.6000 USD 0.0200 0.78%
As of 20:10:00 ET on 12/26/2014.
Company Profile for CytRx Corp (CYTR)
CytRx Corporation is a biopharmaceutical research and development company. The Company focuses in the development of high-value human therapeutics, specializing in oncology. CytRx is also developing two drug candidates based on its molecular chaperone regulation technology.
Key Executives for CytRx Corp (CYTR)
|Steven A KriegsmanPresident/CEO||Jean-Yves Caloz "John"CFO/Treasurer|
|Joseph RubinfeldChief Scientific Advisor||Benjamin S LevinSenior VP/Gen Counsel/Secretary|
|Scott WielandSenior VP:Drug Development||Scott D GeyerSenior VP:Manufacturing|
|David J HaenVP:Business Development||Shanta ChawlaVP:Clinical Development|
|Felix KratzVP:Drug Discovery|